BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update

Date: June 24, 2015
Pages: 53
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B75DB95234BEN
Leaflet:

Download PDF Leaflet

BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update
Summary

BTG plc (BTG) is an international healthcare company that develops manufactures and sells innovative products in specialized areas of medicine. The company undertakes the development of specialty pharmaceutical products including antidotes for the treatment of snake envenomation and toxicity related with medicines used for heart conditions and cancerinterventional vascular products for treating patients with severe blood clots and varicose veins in the great saphenous vein system of the legand interventional oncology products for treating patients with liver tumors. The company develops its own products and acquires or in-licenses them from others. The company markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, the UK, Guernsey, Australia and Germany. BTG is headquartered in London, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BTG Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • BTG Plc Company Snapshot
    BTG Plc Company Overview
    Key Information
    BTG Plc Pipeline Products and Clinical Trials Overview
    BTG Plc – Pipeline Analysis Overview
    Business Description
    Key Facts
    BTG Plc - Major Products and Services
    BTG Plc Pipeline Products by Development Stage
    BTG Plc Clinical Trials by Trial Status
    BTG Plc Pipeline Products Overview
    CellBead - Neuro
    CellBead - Neuro Product Overview
    DC Bead
    DC Bead Product Overview
    DC Bead Clinical Trial
    DC Bead M1
    DC Bead M1 Product Overview
    EKOS EkoSonic SV System - Neuro Vasculature
    EKOS EkoSonic SV System - Neuro Vasculature Product Overview
    RePneu Lung Volume Reduction Coil
    RePneu Lung Volume Reduction Coil Product Overview
    RePneu Lung Volume Reduction Coil Clinical Trial
    TheraSphere - HCC
    TheraSphere - HCC Product Overview
    TheraSphere - HCC Clinical Trial
    TheraSphere - mCRC
    TheraSphere - mCRC Product Overview
    TheraSphere - mCRC Clinical Trial
    Varithena - Aesthetic Leg Veins
    Varithena - Aesthetic Leg Veins Product Overview
    BTG Plc - Key Competitors
    BTG Plc - Key Employees
    BTG Plc - Key Employee Biographies
    BTG Plc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    BTG Plc, Recent Developments
    Jun 11, 2015: First Patient In Singapore Treated With TheraSphere Radioembolization Therapy
    May 19, 2015: BTG announces final results for year ended 31 March 2015
    May 19, 2015: REVOLENS study of PneumRx endobronchial coils in severe emphysema meets primary endpoint
    Apr 01, 2015: BTG begins sale of DC Bead and Bead Block directly to Physicians
    Mar 26, 2015: MHRA helps in the development of a UK manufacturing site for BTG plc for varicose veins treatment
    Dec 19, 2014: BTG Appointment Of Non-Executive Director
    Nov 17, 2014: Dr. Bardwil Performs the First Varithena Treatment in Houston
    Nov 11, 2014: BTG Announces Interim Results
    Oct 20, 2014: PneumRx Completes RENEW Pivotal Trial Enrollment
    Oct 13, 2014: BTG to supply Bead Block directly to physicians in Europe from 1 April 2015
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    BTG Plc, Key Facts
    BTG Plc Pipeline Products and Clinical Trials Overview
    BTG Plc Pipeline Products by Equipment Type
    BTG Plc Pipeline Products by Indication
    BTG Plc Clinical Trials by Trial Status
    BTG Plc, Key Facts
    BTG Plc, Major Products and Services
    BTG Plc Number of Pipeline Products by Development Stage
    BTG Plc Pipeline Products Summary by Development Stage
    BTG Plc Clinical Trials by Trial Status
    BTG Plc Clinical Trials Summary
    CellBead - Neuro - Product Status
    CellBead - Neuro - Product Description
    DC Bead - Product Status
    DC Bead - Product Description
    DC Bead - Post-marketing Surveillance of DC Bead in Patients with Hepatocellular Carcinoma
    DC Bead M1 - Product Status
    DC Bead M1 - Product Description
    EKOS EkoSonic SV System - Neuro Vasculature - Product Status
    EKOS EkoSonic SV System - Neuro Vasculature - Product Description
    RePneu Lung Volume Reduction Coil - Product Status
    RePneu Lung Volume Reduction Coil - Product Description
    RePneu Lung Volume Reduction Coil - Crossover From IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study, IDE G110066
    RePneu Lung Volume Reduction Coil - Evaluation of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of Emphysema in Alpha-1 Antitrypsin Deficient Patients
    RePneu Lung Volume Reduction Coil - Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema
    RePneu Lung Volume Reduction Coil - Lung Volume Reduction Coil Treatment in Patients with Emphysema (RENEW) Study
    RePneu Lung Volume Reduction Coil - Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System
    RePneu Lung Volume Reduction Coil - The Safety and Feasibility of Re-treating Patients with Severe Emphysema with the RePneu LVRC System: A Pilot Study
    TheraSphere - HCC - Product Status
    TheraSphere - HCC - Product Description
    TheraSphere - HCC - A Humanitarian Device Exemption Compassionate Use Protocol of Therasphere for Treatment of Unresectable Metastatic Cancer to the Liver
    TheraSphere - HCC - A Humanitarian Device Exemption Treatment Protocol of Therasphere for the Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - HCC - A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - HCC - A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - HCC - A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - HCC - A Phase II Clinical Trial Evaluating Overall Survival with Therasphere In Conjunction with 2nd-Line FOLFOX In Patients with Gemcitabine-Refractory Pancreatic Carcinoma with Liver Metastases
    TheraSphere - HCC - A Phase III Clinical Trial of Intra-arterial TheraSphere in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC)
    TheraSphere - HCC - A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies with Oligometastases
    TheraSphere - HCC - A Prospective Randomized Clinical Trial on 90Yttrium Trans-arterial Radio-Embolization (TheraSphere) Versus Standard of Care (Sorafenib) for the Treatment of Advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT)
    TheraSphere - HCC - Phase II Study of Intrahepatic Arterial Injection of 90-Y Glass Microspheres as First-line Treatment for Cholangiocarcinoma
    TheraSphere - HCC - Protocol for Use of Therasphere for Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - HCC - TheraSphere Yttrium-90 Glass: Humanitarian Device Exemption Use Protocol for TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
    TheraSphere - mCRC - Product Status
    TheraSphere - mCRC - Product Description
    TheraSphere - mCRC - A Phase III Clinical Trial Evaluating Therasphere in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
    TheraSphere - mCRC - An Open-label, Multicenter, Phase II Trial, to Evaluate the Efficacy of Intra-hepatic Administration of Yttrium 90-labelled Microspheres (Therasphere, Nordion) in Association with Intravenous Chemotherapy with Gemcitabine and Cisplatin for the Treatment of Intra-hepatic Cholangiocarcinoma, First Line
    Varithena - Aesthetic Leg Veins - Product Status
    Varithena - Aesthetic Leg Veins - Product Description
    BTG Plc, Key Employees
    BTG Plc, Key Employee Biographies
    BTG Plc, Subsidiaries

    LIST OF FIGURES

    BTG Plc Pipeline Products by Equipment Type
    BTG Plc Pipeline Products by Development Stage
    BTG Plc Clinical Trials by Trial Status
    Skip to top


    Ask Your Question

    BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: